Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
On this page:OverviewPublicationsKey papers
ScholarIQanswers from OpenAlex & ORCID

Hamza Irfan

ResearcherPublications, citations & collaboration network

Hamza Irfan is a researcher indexed in ScholarIQ from OpenAlex & ORCID. ScholarIQ records 62 works, 426 citations, an h-index of 10 and an i10-index of 10.

62
Works
426
Citations
10
h-index
10
i10-index

How has Hamza Irfan's publication output changed over time?

ScholarIQpublication output · 2023–2025

Output declined33% over the shown period — from 3 works in 2023 to 2 in 2025.

3
6
2
202320242025

What are the most-cited papers on Hamza Irfan?

ScholarIQmost cited works
Revolutionary breakthrough: FDA approves CASGEVY, the first CRISPR/Cas9 gene therapy for sickle cell disease
Ajeet Singh, Hamza Irfan, Eeshal Fatima, Zainab Nazir, Amogh Verma, Aymar Akilimali
Annals of Medicine and Surgery. 202487 CitationsOPEN ACCESS
Impacts of the advancement in artificial intelligence on laboratory medicine in low‐ and middle‐income countries: Challenges and recommendations—A literature review
Malik Olatunde Oduoye, Eeshal Fatima, Muhammad Ali Muzammil, Tirth Dave, Hamza Irfan, Fnu Fariha, Andrew Marbell, Samuel Chinonso Ubechu, Godfred Yawson Scott, Emmanuel Ebuka Elebesunu
Health Science Reports. 202462 CitationsOPEN ACCESS
Microplastics and nanoplastics: emerging threats to cardiovascular health – a comprehensive review
Hamza Irfan, Haider Irfan, M. A. Khan, Öykü İnanç, Md. Al Hasibuzzaman
Annals of Medicine and Surgery. 202427 CitationsOPEN ACCESS

Related on ScholarIQ

Shaikh Zayed Medical College and Hospital
Institution
Revolutionary breakthrough: FDA approves CASGEVY, the first CRISPR/Cas9 gene therapy for sickle cell disease
Paper
Impacts of the advancement in artificial intelligence on laboratory medicine in low‐ and middle‐income countries: Challenges and recommendations—A literature review
Paper
Obesity, Cardiovascular Disease, and the Promising Role of Semaglutide: Insights from the SELECT Trial
Paper
Air pollution and cardiovascular health in South Asia: A comprehensive review
Paper
Microplastics and nanoplastics: emerging threats to cardiovascular health – a comprehensive review
Paper
470M+ articles · free account